0001209191-17-048673.txt : 20170811 0001209191-17-048673.hdr.sgml : 20170811 20170811200305 ACCESSION NUMBER: 0001209191-17-048673 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170810 FILED AS OF DATE: 20170811 DATE AS OF CHANGE: 20170811 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dubensky Thomas W. CENTRAL INDEX KEY: 0001635590 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37345 FILM NUMBER: 171026582 MAIL ADDRESS: STREET 1: C/O ADURO BIOTECH, INC. STREET 2: 740 HEINZ AVENUE CITY: BERKELEY STATE: CA ZIP: 94710 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ADURO BIOTECH, INC. CENTRAL INDEX KEY: 0001435049 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 740 HEINZ AVENUE CITY: BERKELEY STATE: CA ZIP: 94710 BUSINESS PHONE: 510-848-4400 MAIL ADDRESS: STREET 1: 740 HEINZ AVENUE CITY: BERKELEY STATE: CA ZIP: 94710 FORMER COMPANY: FORMER CONFORMED NAME: ADURO BIOTECH DATE OF NAME CHANGE: 20080514 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-08-10 0 0001435049 ADURO BIOTECH, INC. ADRO 0001635590 Dubensky Thomas W. C/O ADURO BIOTECH, INC. 740 HEINZ AVENUE BERKELEY CA 94710 0 1 0 0 Chief Scientific Officer Common Stock 2017-08-10 4 M 0 40912 1.00 A 80812 D Common Stock 2017-08-10 4 S 0 40912 11.431 D 39900 D Common Stock 2017-08-11 4 M 0 9088 1.00 A 48988 D Common Stock 2017-08-11 4 S 0 9088 11.1728 D 39900 D Stock Option (Right to Buy) 1.00 2017-08-10 4 M 0 40912 0.00 D 2024-07-30 Common Stock 40912 135416 D Stock Option (Right to Buy) 1.00 2017-08-11 4 M 0 9088 0.00 D 2024-07-30 Common Stock 9088 126328 D The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2017. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.10 to $12.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.10 to $11.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The shares subject to the Option vest in 48 equal monthly installments from the vesting commencement date of July 31, 2014. /s/ Jennifer Lew, Attorney-in-Fact 2017-08-11